Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT

    NEXT STORY
    Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
    PREV STORY
    Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and Highlights
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

    SEATTLE, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting

    author_avatar
    NASDAQ Market News

    Outlook on the Worldwide Hand Sanitizer Industry to 2027 – Players Profiled Include Unilever, The Himalaya Drug Company and Ecolab Among Others

    author_avatar
    NASDAQ Market News